Dog /

Breed profile · FDA CVM July 2026 extract

Retriever - Flat-coated adverse-event record

Adverse-event filings for Retriever - Flat-coated (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#152 of 510
by report volume (all breeds)
405
FDA CVM reports on file
4.0%
death-coded share of reports
#182 of 275
by death-coded share (≥50 reports)

How the 405 reports break down

By recorded gender -- every report on file for Retriever - Flat-coated, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 35 26.25 17.5 8.75 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Retriever - Flat-coated drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Retriever - Flat-coated ranks #152 of 510 by total reports (405) and #182 of 275 by death-coded share (4.0%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#152
This breed, reports of 510
#182
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Retriever - Flat-coated has 405 reports now versus 399 in that prior snapshot: 6 more (1.5%).

Report change
+6
Death-coded reports
+0
Death-coded share
−0.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Retriever - Flat-coated changes

Total Reports

405

Above-median volume

Deaths Reported

16

of 405 reports

Death-coded share of reports

4.0%

Below-median death-coded share

Avg Age at Report

5.4 yr

29.5 kg avg weight

Breed Safety Scorecard

D (46/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate B-
4.0%

Share of reports coded as a fatality

Euthanasia rate D
2.2%

Share of reports resulting in euthanasia

Full recovery rate D
28.1%

Share of reports coded "Recovered/Normal"

5-year trend F
+100%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Retriever - Flat-coated death-coded reports 4.0%
Cross-breed median

4.0% of 405 retriever - flat-coated reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Retriever - Flat-coated's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

4% 34th percentile Higher share than 34% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Retriever - Flat-coated 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 29.5 kg (65.0 lbs)

Top Reported Reactions

Vomiting 59
Diarrhoea 37
Lethargy (see also Central nervous system depression in 'Neurological') 37
Lack of efficacy (endoparasite) - hookworm 30
Emesis 28
Lack of efficacy (endoparasite) - heartworm 26
Digestive tract disorder NOS 24
Lack of efficacy - NOS 23

Most Referenced Drugs

Ivermectin + Pyrantel As Pamoate Salt 57
Milbemycin Oxime + Spinosad 55
Afoxolaner 26
Pyrantel Pamoate;Sarolaner 25
Spinosad 20
Carprofen 20
Milbemycin Oxime + Praziquantel 20
Oclacitinib Maleate 15

Outcome Breakdown

Outcome Unknown
129 (34.2%)
Recovered/Normal
114 (30.2%)
Ongoing
103 (27.3%)
Recovered with Sequela
15 (4.0%)
Euthanized
9 (2.4%)
Died
7 (1.9%)

Gender Distribution

Male 238 (58.8%)
Female 160 (39.5%)
Unknown 5 (1.2%)
Mixed 2 (0.5%)

Reports by Year

Year Reports Trend
2010 8
2011 23
2012 22
2013 32
2014 34
2015 28
2016 32
2017 35
2018 32
2019 25
2020 26
2021 12
2022 16
2023 17
2024 35
2025 24
2026 4

Retriever - Flat-coated: high-volume FDA adverse-event cohort

Signature read: 405 reports place Retriever - Flat-coated in the upper third of breed filing volume (#152 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Retriever - Flat-coated sits at #152 of 510 by report volume among all breeds and #124 of 298 among dog breeds, with 405 reports and 16 (4.0%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #182 of 275. Mean age at report: 5.4 years, average weight 29.5 kg (65.0 lbs).

Top reported signs: Vomiting (59), Diarrhoea (37), Lethargy (see also Central nervous system depression in 'Neurological') (37). Most-referenced drug: Ivermectin + Pyrantel As Pamoate Salt (57 reports), followed by Milbemycin Oxime + Spinosad (55) and Afoxolaner (26).

Outcome coding on 377 status-recorded reports is dominated by Outcome Unknown (34.2%). Annual submissions ranged 4-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Retriever - Flat-coated drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (4.0% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (29.5 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Retriever - Flat-coated?
There are 405 adverse event reports involving Retriever - Flat-coated in the FDA database, of which 16 were death-coded (4.0% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Retriever - Flat-coated ranks #152 of 510 by report volume among all breeds PlainBreed indexes (#124 of 298 among dog breeds).
Where does Retriever - Flat-coated sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Retriever - Flat-coated is #152 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #124 of 298. Among breeds with at least 50 reports, its death-coded share ranks #182 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Retriever - Flat-coated?
The most commonly reported adverse reactions for Retriever - Flat-coated are Vomiting (59 reports), Diarrhoea (37 reports), Lethargy (see also Central nervous system depression in 'Neurological') (37 reports), Lack of efficacy (endoparasite) - hookworm (30 reports), Emesis (28 reports).
What drugs are most frequently associated with Retriever - Flat-coated adverse events?
The drugs most frequently referenced in Retriever - Flat-coated adverse event reports are Ivermectin + Pyrantel As Pamoate Salt (57 reports), Milbemycin Oxime + Spinosad (55 reports), Afoxolaner (26 reports), Pyrantel Pamoate;Sarolaner (25 reports), Spinosad (20 reports).
What is the average age of Retriever - Flat-coated in adverse event reports?
The average age of Retriever - Flat-coated at the time of adverse event reports is 5.4 years, with an average weight of 29.5 kg (65.0 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Retriever - Flat-coated (Dog), extract as of July 2026 extract. 405 reports · 16 death-coded (4.0% of reports, not a mortality rate) · #152 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →